1. Home
  2. CCBG vs ZVRA Comparison

CCBG vs ZVRA Comparison

Compare CCBG & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital City Bank Group

CCBG

Capital City Bank Group

N/A

Current Price

$49.57

Market Cap

828.1M

Sector

Finance

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$9.09

Market Cap

664.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCBG
ZVRA
Founded
1895
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
828.1M
664.7M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CCBG
ZVRA
Price
$49.57
$9.09
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
★ $53.83
$23.00
AVG Volume (30 Days)
61.4K
★ 980.7K
Earning Date
10-20-2026
11-03-2026
Dividend Yield
★ 2.17%
N/A
EPS Growth
15.38
★ 159.21
EPS
★ 2.86
1.03
Revenue
N/A
★ $106,470,000.00
Revenue This Year
$1.18
$43.81
Revenue Next Year
$3.29
$15.30
P/E Ratio
$17.49
★ $9.02
Revenue Growth
N/A
★ 350.91
52 Week Low
$39.26
$8.01
52 Week High
$53.60
$15.04

Technical Indicators

Market Signals
Indicator
CCBG
ZVRA
Relative Strength Index (RSI) 43.16 37.87
Support Level $47.63 $9.03
Resistance Level $51.93 $9.24
Average True Range (ATR) 1.16 0.66
MACD -0.19 -0.20
Stochastic Oscillator 19.19 3.66

Price Performance

Historical Comparison
CCBG
ZVRA

About CCBG Capital City Bank Group

Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: